electroCore to Announce Second Quarter 2019 Financial Results on Tuesday, August 13
Tuesday, August 13th @ 4:30pm Eastern Time | |
Domestic: | 877-407-4018 |
International: | 201-689-8471 |
Conference ID: | 13692585 |
Webcast: | http://public.viavid.com/index.php?id=135360 |
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Investors:
LifeSci Advisors
(+1) 617-535-7743
hans@lifesciadvisors.com
or
Media Contact:
LifeSci Public Relations
(+1) 646-876-4933
sara@lifescipublicrelations.com